Results 41 to 50 of about 179,968 (219)

Thyroid carcinoma with atypical metastasis to the pituitary gland and unexpected postmortal diagnosis

Endocrinology, Diabetes & Metabolism Case Reports, 2020
Papillary thyroid gland carcinoma is the most common type of malignancy of the endocrine system. Metastases to the pituitary gland have been described as a complication of papillary thyroid cancer in few reported cases since 1965. We report the case of a
Anna Popławska-Kita, Marta Wielogórska, Łukasz Poplawski, Katarzyna Siewko, Agnieszka Adamska, Piotr Szumowski, Piotr Myśliwiec, Janusz Myśliwiec, Joanna Reszeć, Grzegorz Kamiński, Janusz Dzięcioł, Dorota Tobiaszewska, Małgorzata Szelachowska, Adam Jacek Krętowski   +13 more
doaj   +1 more source

Serum osteopontin can improve papillary thyroid cancer risk assessment of Bethesda III thyroid nodules: a preliminary study

Endocrine Oncology, 2023
Objective: Thyroid cancer can be detected in 5–10% of patients with thyroid nodules. Management may be a challenge if fine-needle aspiration biopsy yields Bethesda III findings. Most of these cases undergo surgery and are ultimately found benign. Our aim
T U Kars, M Kulaksızoğlu, İ Kılınç
doaj   +1 more source

Contemporary debates in adult papillary thyroid cancer management.

Endocrine reviews, 2019
An ever-increasing population of patients with differentiated thyroid cancer is engaging with healthcare systems around the world. Numerous questions about optimal management have arisen that challenge conventional paradigms.
D. McLeod, Ling Zhang, C. Durante, D. Cooper   +3 more
semanticscholar   +1 more source

Comparison of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in patients with thyroiditis and papillary tumors

Journal of International Medical Research, 2019
Objective The neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) have recently been introduced as prognostic markers of thyroid cancer and strong inflammatory markers.
Aziz Ari, Feray Gunver
doaj   +1 more source

Case report: Lymph node metastases of breast cancer and thyroid cancer encountered in axilla

Frontiers in Oncology, 2022
Occurrences of breast cancer and thyroid cancer metachronously or synchronously are common for women, but axillary lymph node metastasis from both cancers is rarely seen.
Rihan Li, Rihan Li, Qingfu Zhang, Dongdong Feng, Dongdong Feng, Feng Jin, Siyuan Han, Siyuan Han, Xinmiao Yu, Xinmiao Yu   +9 more
doaj   +1 more source

Gender-Specific Variation in the Prognosis of Papillary Thyroid Cancer TNM Stages II to IV

International Journal of Endocrinology, 2012
To investigate the correlation between gender and the clinical presentation of papillary thyroid cancer and the long-term followup results, 435 patients who underwent total or near-total thyroidectomy were enrolled in this study.
Sheng-Hwu Hsieh, Szu-Tah Chen, Chuen Hsueh, Tzu-Chieh Chao, Jen-Der Lin   +4 more
doaj   +1 more source

Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report

Frontiers in Oncology, 2022
Little is known about the efficacy of alectinib for papillary thyroid cancer with STRN-ALK fusion. A 64-year-old female presented with metastatic papillary thyroid cancer, widespread to lungs, mediastinal lymph nodes and brain 20 years after surgery ...
Lucheng Zhu, Lucheng Zhu, Shenglin Ma, Bing Xia, Bing Xia   +4 more
doaj   +1 more source

Pathophysiology of tumor progression and possibilities of using polarization biomedical optics methods in the diagnosis of papillary thyroid cancer

Mìžnarodnij Endokrinologìčnij Žurnal
Background. Clinical diagnosis of papillary thyroid cancer usually occurs at the stage of tumor progression accompanied by intensive processes of growth, invasion, formation of blood vessels to provide blood supply to the tumor, the structure and ...
Yu.Ye. Rohovyi, O.V. Bilookyi, O.H. Ushenko, V.V. Bilookyi   +3 more
doaj   +1 more source

ANALYSIS OF RELAPSE RATE AND METASTASES OF HIGH DIFFERENTIATED THYROID CANCER

Опухоли головы и шеи, 2015
Analysis of rate of relapses and metastases with well-differentiated thyroid cancer was performed for patients in 2009 to 2013. The study involved 189 patients with thyroid cancer including 98 (51.9 %) patients suffering from papillary thyroid cancer, 77
E. V. Savenok, E. S. Minakova, O. V. Ryzhikh, E. D. Panov, E. A. Karapetyan   +4 more
doaj   +1 more source

Increased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancer. [PDF]

PLoS ONE, 2012
A good prognosis can be expected for most, but not all, cases of thyroid papillary cancer. Numerous molecular studies have demonstrated beneficial treatment and prognostic factors in various molecular markers.
Seiji Ishikawa, Ichiro Tateya, Takahiro Hayasaka, Noritaka Masaki, Yoshinori Takizawa, Satoshi Ohno, Tsuyoshi Kojima, Yoshiharu Kitani, Morimasa Kitamura, Shigeru Hirano, Mitsutoshi Setou, Juichi Ito   +11 more
doaj   +1 more source